Clinical trials
Active, not recruiting Phase 2 Diabetes Mellitus, Type 2 trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 2 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 5 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 23 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 3 |
| Jiangsu HengRui Medicine Co., Ltd. | 2 |
| Amgen | 1 |
| Antag Therapeutics | 1 |
| Biomea Fusion Inc. | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Corcept Therapeutics | 1 |
| Gan & Lee Pharmaceuticals. | 1 |
| Guangdong Raynovent Biotech Co., Ltd | 1 |
| Hoffmann-La Roche | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 23 |
| Obesity | 5 |
| Non-alcoholic Fatty Liver Disease | 2 |
| Overweight | 2 |
| ACTH Syndrome, Ectopic | 1 |
| Adrenal Cortex Neoplasms | 1 |
| Adrenocortical Carcinoma | 1 |
| Body Weight | 1 |
| Bone Diseases, Metabolic | 1 |
| Cardiovascular Diseases | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.